| Size | Price | Stock | Qty |
|---|---|---|---|
| 100mg |
|
||
| 500mg |
|
||
| Other Sizes |
| Targets |
Adipic acid-13C does not have a specific pharmacological receptor target. As a stable isotope-labeled compound, it is used as a tracer in metabolic studies. Adipic acid itself is an endogenous metabolite associated with various inborn errors of metabolism. The 13C labeling allows for the tracking of its metabolic fate in biological systems.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
In vitro, Adipic acid-13C is not used for conventional biological activity assays. Its primary utility is as a tracer in metabolic studies. Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules as tracers for quantitation during the drug development process. Adipic acid, the unlabeled compound, has anti-HSV-1 activity. |
| ln Vivo |
In vivo, Adipic acid-13C is used as a metabolic tracer to study fatty acid metabolism and to diagnose inborn errors of metabolism. By administering the labeled compound and measuring the incorporation of 13C into downstream metabolites using mass spectrometry, researchers can map metabolic pathways. It is not used for therapeutic purposes.
|
| Enzyme Assay |
For non-cell-based assays, Adipic acid-13C is used as an analytical standard. Its identity and purity are confirmed using techniques such as NMR, HPLC, and mass spectrometry. It is not used in receptor binding assays. Its role is to serve as a quantitative tracer in metabolic studies, enabling the tracking of carbon atoms through metabolic pathways.
|
| Cell Assay |
For in vitro cellular assays, cells are cultured in media containing Adipic acid-13C. The compound is taken up by cells and metabolized through various pathways. After a defined incubation period, cells are harvested, and metabolites are extracted. The incorporation of 13C into metabolites is analyzed using LC-MS/MS or GC-MS to determine metabolic fluxes and pathway activities.
|
| Animal Protocol |
For in vivo animal studies, Adipic acid-13C can be administered to rodents via oral gavage. Blood or tissue samples are collected at various time points post-administration. The samples are processed and analyzed by mass spectrometry to track the distribution and metabolism of the labeled compound. This allows for the study of fatty acid metabolism and related metabolic disorders.
|
| ADME/Pharmacokinetics |
Adipic acid-13C has a molecular weight of 147.13 g/mol and a molecular formula of C5^{13}CH10O4. It is soluble in DMSO at 100 mg/mL (679.67 mM). The compound should be stored at -20°C for up to 3 years or at 4°C for up to 2 years. In solvent, it can be stored at -80°C for 6 months or at -20°C for 1 month. It is for research use only and is not intended for human consumption.
|
| Toxicity/Toxicokinetics |
The toxicity profile of Adipic acid-13C is not applicable, as it is used as a metabolic tracer at very low concentrations. Adipic acid itself has low toxicity. The 13C labeling is not expected to introduce new toxicities, as carbon-13 is a stable, non-radioactive isotope. The compound is not intended for human consumption. Standard safety precautions should be observed when handling the compound.
|
| References | |
| Additional Infomation |
Adipic acid-13C (CAS 2708283-72-9) is the 13C-labeled form of adipic acid. Adipic acid is an orally active compound with anti-HSV-1 activity and low toxicity. It is used as a food additive and a gelling agent. Adipic acid-13C is used as a tracer in metabolic studies and for the diagnosis of inborn errors of metabolism. It is available for research purposes only.
|
| Molecular Formula |
C6H10O4
|
|---|---|
| Molecular Weight |
147.133857250214
|
| Exact Mass |
147.061
|
| CAS # |
2708283-72-9
|
| Related CAS # |
Adipic acid;124-04-9
|
| PubChem CID |
162343593
|
| Appearance |
White to off-white solid powder
|
| LogP |
0.1
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
10
|
| Complexity |
114
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[13C](O)(=O)CCCCC(O)=O
|
| InChi Key |
WNLRTRBMVRJNCN-HOSYLAQJSA-N
|
| InChi Code |
InChI=1S/C6H10O4/c7-5(8)3-1-2-4-6(9)10/h1-4H2,(H,7,8)(H,9,10)/i5+1
|
| Chemical Name |
(113C)hexanedioic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~100 mg/mL (~679.7 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (16.99 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 400 μL of PEG300 and mix well; then add 50 μL of Tween-80 and mix well; finally add 450 μL of physiological saline and adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (16.99 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (16.99 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.7967 mL | 33.9836 mL | 67.9671 mL | |
| 5 mM | 1.3593 mL | 6.7967 mL | 13.5934 mL | |
| 10 mM | 0.6797 mL | 3.3984 mL | 6.7967 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
